Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012349) titled 'An 8-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lactobacillus paracasei HY7017 in enhancing immune function' on July 28.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Vievis Namuh Hospital
Condition:
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Intervention:
Dietary Supplement : Participants who voluntarily sign the informed consen...